Prevas AB (plc) engaged Lindahl as a legal advisor in the acquisition of all shares of the consulting group Evotech as well as the remaining minority shareholdings in the operating subsidiaries Tritech Technology and Deva Mecaneyes. Through the acquisition, the company profoundly strengthens its position in terms of product development and production development.
The total value of the acquired shares is roughly SEK 270 million, and the acquisition was paid for through a combination of cash and non-cash issued shares in Prevas.
Lindahl’s legal team was made up Mats Tindberg (senior partner), Nicklas Bexelius (M&A), Monica Lagercrantz and Ola Svanberg (stock market), as well as Gustav Ahlgren and Mikael Nagy.
The transaction is contingent on a decision taken by an EGM in Prevas, on the Swedish Financial Supervisory Authority’s approval of a prospectus and on the Swedish Competition Authority’s permission to allow the transaction.
